Skip to main content
. 2022 Jun 23;7:19. doi: 10.1186/s41256-022-00251-5

Table 3.

Most frequent adverse events

AEs* Experimental Control Total Articles
Increased respiratory rate 30 34 64 [16]
Increased blood pressure 20 20 40 [16, 20, 26]
Fever 17 22 39 [15, 16, 20, 26]
Elevated ALT 19 15 34 [18, 20]
Anemia 15 17 32 [15, 16, 26]
Sepsis 6 15 21 [15, 16]
Deaths with no cause reported 6 14 20 [15, 16]
Decreased absolute lymphocyte 8 9 17 [16]
Elevated LDH 10 7 17 [18, 26]
Disease progression 5 9 14 [16]
Hypokalemia 9 3 12 [15, 18, 26]
Bacterial infections 9 3 12 [15, 18, 25]
Metabolic alkalosis 5 6 11 [16, 18]
Acute Respiratory Distress Syndrome 4 7 11 [16, 26]
Multiple organ failure 3 8 11 [16, 26]

*AEs occurring a total of more than 10 times in all studies